---
title: "Ad Law News and Views - June 13, 2020"
date: 2020-06-13T00:00:00-04:00
author: Import Bot
canonical_url: "https://www.kelleydrye.com/viewpoints/newsletters/ad-law-news-and-views/ad-law-news-and-views-june-13-2020"
section: Newsletter Issues
---
# Ad Law News and Views - June 13, 2020

 June 13, 2020

 

 

 

 

 

 

### RECENT NEWS

#### [Lessons Learned for Maintaining Attorney-Client Privileged Data Breach Investigation (and other Consultant) Reports](https://www.adlawaccess.com/2020/06/articles/lessons-learned-for-maintaining-attorney-client-privileged-data-breach-investigation-and-other-consultant-reports/)

#### [NAD Addresses Implied Coronavirus Cure Claims](https://communications.kelleydrye.com/e/7e6l1nb2fpa41w)

#### [Big Little Material Omissions: Reese Witherspoon and Draper James Subject of Class Action Lawsuit](https://communications.kelleydrye.com/e/olkyzi1x3zxxtjg)

#### [FTC COPPA Settlement Shows Ongoing Rift Over Privacy Harm](https://communications.kelleydrye.com/e/fwkgydtnnefcwpg)

#### [EPA Cautions Consumers About Ozone Generators, UV Lights, and Other Pesticide Devices Making Coronavirus Claims](https://communications.kelleydrye.com/e/0ksp2jmdnsu3aw)

Receive posts as they happen by subscribing to the **[Ad Law Access blog](https://communications.kelleydrye.com/e/mh0a7bwvnijkvw) by [email](https://communications.kelleydrye.com/e/1uszntlgcnp6sq) or [RSS feed.](https://communications.kelleydrye.com/e/0bk4kra26brw)**

### ON DEMAND CONTENT

We have pulled together a selection of on demand content that we hope you find useful:

#### PODCASTS

- #### [Health Claims 101: Key Considerations For Making Compliant Health Claims](https://communications.kelleydrye.com/e/4egmiston1mlug)
- #### [Operationalizing the California Consumer Privacy Act (CCPA) ](https://communications.kelleydrye.com/e/wlkskamqalpwhuq)
- #### [Green Marketing](https://communications.kelleydrye.com/e/kn0cg11bh84gdw)
- #### [Health Claims in the Context of COVID-19](https://communications.kelleydrye.com/e/gr0ukt1tqpzybq)
- #### [Answering Retailer Questions Related to COVID-19 Issues](https://communications.kelleydrye.com/e/hhkymrbrbag16q)
- #### [Update on ATDS Definition Under the TCPA](https://communications.kelleydrye.com/e/op0e9zhdidlaqgq)
- #### [Price Gouging](https://communications.kelleydrye.com/e/qne6vxrzeadmww)

The Ad Law Access podcast is available now through [Apple](https://communications.kelleydrye.com/e/d0eteml4xa0sg), [Spotify](https://communications.kelleydrye.com/e/d20wzb0xedvgcka), [Google Podcasts](https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjU5OTgyMTEwNC9zb3VuZHMucnNz?sa=X&ved=0CAYQrrcFahcKEwjYzuHg-6TrAhUAAAAAHQAAAAAQAQ), [SoundCloud](https://communications.kelleydrye.com/e/4402tildxmbkvaa), and [wherever you get your podcasts](https://communications.kelleydrye.com/e/o0mjslshw0bva)[.](https://communications.kelleydrye.com/e/aheqigavnildpq)

#### WEBINARS

This year, in conjunction with the launch of the [Advertising and Privacy Law Resource Center](https://communications.kelleydrye.com/e/tnua67huro071w), we have been holding a series of webinars:

- #### [Advertising 101 Webinar](https://communications.kelleydrye.com/e/ab0ks8rwa9zozg)
- #### **[Privacy 101 Webinar](https://communications.kelleydrye.com/e/jzue9yoz8kwte8w)**
- #### **[Influencer 101 Webinar](https://communications.kelleydrye.com/e/rc0uesnj6punbw)**
- #### **[Pretty Up: Cosmetics False Advertising Litigation Trends and Marketing Compliance Webinar](https://communications.kelleydrye.com/e/dkewjjj2ujvbreq)**

We will announce the next series of webinars soon.

###   
COVID-19 RESOURCES

In addition to the webinars mentioned above, Kelley Drye is making the following COVID-19 resources available:

#### KELLEY DRYE’S COVID-19 RESPONSE

Kelley Drye’s **[COVID-19 Response Resource Center](https://communications.kelleydrye.com/e/byuc0eguqpadylq)** is a dedicated source that provides guidance and addresses questions about legal and business concerns arising from the Coronavirus outbreak. Our priority is to closely monitor and track developments to help you stay informed, so that you can respond to the shifting landscape. To receive Kelley Drye’s updates on COVID-19 legal issues, **[sign up here](https://communications.kelleydrye.com/e/ehkdcc5lhupfkq).**

#### COVID-19 DAILY WASHINGTON UPDATE

The Washington Update is a daily synopsis of federal government actions related to the COVID-19 pandemic. The synopsis covers actions coming from Congress, the White House and various federal agencies, including the CDC, the Departments of Labor, Health and Human Services, Homeland Security and Treasury/IRS, the Food and Drug Administration and the Federal Trade Commission, among others. You can sign up to receive the daily Washington Update by subscribing to our COVID-19 interest area **[here](https://communications.kelleydrye.com/e/bkeaoe83balweg).** Archived editions of the Washington Update can be found **[here](https://communications.kelleydrye.com/e/ts0yv0j1d3tdzxq).**

#### COMMLAW MONITOR

As the COVID-19 pandemic rapidly unfolds, the Federal Communications Commission (FCC) has been active to keep communications services available through various waivers, extensions, and other regulatory relief. Kelley Drye’s Communications Practice Group is tracking these actions and what they mean for communications service providers and their customers. **[CommLaw Monitor](https://communications.kelleydrye.com/e/zh0asfwrmcia48a)** will provide regular updates to its analysis of the latest regulatory and legislative actions impacting your business and the communications industry. Click on the ​“**[COVID-19](https://communications.kelleydrye.com/e/uf0aahopl55wfoa)**” blog category for previous updates. If you have any urgent questions, please contact your usual Kelley Drye attorney or any member of the **[Communications Practice Group](https://communications.kelleydrye.com/e/hqucbg7924wpm4g).**

### **IN CASE YOU MISSED IT**

#### [CCPA Update: Final Regulations Submitted but No Changes from Prior Draft](https://communications.kelleydrye.com/e/9iuat6n5ls5ula)

#### [Another Federal Court Halts False Advertising Case Pending FDA Review of CBD](https://communications.kelleydrye.com/e/xqkclvn8n25w9tw)

#### [EPA Issues Consumer Advisory on Products Claiming to Kill Coronavirus](https://communications.kelleydrye.com/e/aekmgeo0iwxno4a)

#### [Executive Order Strikes at Section 230, But Legal Impact Likely to be Limited](https://communications.kelleydrye.com/e/cukkeetmceldlw)

#### [Another Slack Fill Preemption Win for the Cosmetics Industry in Critcher v. L’Oreal](https://communications.kelleydrye.com/e/sge6tqxofyfygww)

#### [Keep Calm and Go Online: Regulatory Considerations Around the Spike in Demand for Mental Health Apps](https://communications.kelleydrye.com/e/yxu2zlgzsd86ca)

#### [FDA and FTC Joint Warning Letters Target Amazon Affiliates Making False COVID-19 Claims](https://communications.kelleydrye.com/e/ygeag1x6cinrgag)

 

 

 - Share this entry 
    - 
    - 
    - 
    -
- [  View entry pdf ](https://s3.amazonaws.com/cdn.kelleydrye.com/content/uploads/pdf-snapshots/ad-law-news-and-views-june-13-2020-20230913222750.pdf)
 
 

### Related Services

- [California Consumer Privacy Act (CCPA)](https://www.kelleydrye.com/trending/california-consumer-privacy-act-ccpa)
- [General Data Protection Regulation (GDPR)](https://www.kelleydrye.com/trending/general-data-protection-regulation-gdpr)
- [Dietary Supplements and Functional Foods](https://www.kelleydrye.com/industries/dietary-supplements-and-functional-foods)
- [Consumer Class Action Defense](https://www.kelleydrye.com/practices/consumer-class-action-defense)
- [Advertising and Marketing](https://www.kelleydrye.com/practices/advertising-and-marketing)
- [Antitrust](https://www.kelleydrye.com/practices/antitrust)
- [Consumer Product Safety Regulation](https://www.kelleydrye.com/practices/consumer-product-safety-regulation)
- [Privacy and Information Security](https://www.kelleydrye.com/practices/privacy-and-information-security)
- [Food and Drug](https://www.kelleydrye.com/industries/food-and-drug)
